세계 최대 골드 관련 750개 기업 중 우리 회사의 리서치를 바탕으로
투자 기준에 부합한 200개 회사를 선정하여 고객의 투자 성향에 맞는
고수익 포트폴리오를 구성하고 실시간으로 업데이트된 기업 정보와
리스크관리를 통해 안정적이면서 고수익을 창출할 수 있는 투자전략을 제공합니다.
Portfolio
- Guiding Principles
ANNUAL RETURN
- Generate a steady 25% return per annum
GENERATING STEADY RETURN IN THE VOLATILE SECTOR
- Tiered portfolio strategy, tight risk management, and avoiding large losses are key to generating a steady return
PORTFOLIO STRATEGY
- Stay disciplined and stick with the portfolio strategy
- Portfolio strategy is designed to generating a cumulative and steady return plus selective alpha return
MANAGE RISK
- Follow basic risk management principles
- Focus on the five risk factors unique to bio stocks
FUNDAMENTAL RESEARCH
- Conduct thorough fundamental research before initiating a new position
- Understand the five key risk factors unique to bio stocks (listed next page)
MARGIN OF SAFETY
- Strictly adhere to the margin of safety rule
VOLATILITY
- Utilize market risk volatility as opportunities to enhance return
- Balance price volatility between general market risk and company-specific risk
Portfolio
- Structure
OBJECTIVE
Objective is to identify the alpha-generating winners through deep dive fundamental research and disciplined execution of portfolio strategy and risk management
PRIMARY FILTERING CRITERIA
- Market cap size
- Drug therapy field & technology
- Leading bio institutional investor presence
- Biotech analyst coverage
- Catalyst & catalyst timing
~750 Nasdaq- listed BIO Companies